Opioid-Induced Constipation market is valued at 2110 million US$ in 2018 is expected to reach 3060 million US$ by the end of 2025, growing at a CAGR of 4.8% during 2019-2025

Market and Industry Analytics

Opioid-Induced Constipation market is valued at 2110 million US$ in 2018 is expected to reach 3060 million US$ by the end of 2025, growing at a CAGR of 4.8% during 2019-2025

Press Release

Opioids are administered to the patients with acute and non-cancer chronic pain. They have several adverse gastrointestinal effects, one of which is opioid-induced constipation. Opioids are administered to the patients with acute and non-cancer chronic pain. They have several adverse gastrointestinal effects, one of which is opioid-induced constipation.
Opioid-Induced Constipation is widely sold in Hospital, Pharmacy and other field. The most proportion of Opioid-Induced Constipation is sold in Pharmacy, and the proportion in 2017 is 45.99%.
North America is the largest Sales place, with a Sales market share nearly 56.48% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 20.49%.

The global Opioid-Induced Constipation market is valued at 2110 million US$ in 2018 is expected to reach 3060 million US$ by the end of 2025, growing at a CAGR of 4.8% during 2019-2025.
This report focuses on Opioid-Induced Constipation volume and value at global level, regional level and company level. From a global perspective, this report represents overall Opioid-Induced Constipation market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The report includes an in-depth analysis of the competitive landscape of this business vertical, constituting manufacturers like:
Takeda Pharmaceuticals
Bayer
Sanofi
Mallinckrodt
Salix (Bausch Health)
AstraZeneca
Progenics Pharmaceuticals
Purdue Pharm
Nektar Therapeutics
Daiichi Sankyo
Prestige
GSK
Shionogi

Market Segment by Regions includes:
North America
Europe
China
Japan

Products Segmentation, this report displays the production, revenue, price, market share, and growth rate of each type as below:
Methylnaltrexone Bromide
Lubiprostone
Naloxegol
Other

By Industrial Application and End-user Application, the market is split into below:
Hospital
Pharmacy
Other

Global Opioid-Induced Constipation Market Research Report 2019 is a professional and in-depth study and available exclusively through Trusted Business Insights. Annual estimates and forecasts are provided for the period 2019 through 2025. Also, a five-year historic analysis is provided for these markets in this 100 pages report.

This market report provides in-depth analytics of the Opioid-Induced Constipation industry including definition, classification, application and industry chain structure. The report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share, and contact information.

Request for a Sample PDF of Opioid-Induced Constipation research report

The scope of the Opioid-Induced Constipation market report is as below:

– The report provides information on growth segments and opportunities for investment and Benchmark performance against key competitors.

– The research of emerging Opioid-Induced Constipation market provides the segments, and the existing market segments will help the investors or new business entrants in planning the business strategies accordingly.

– The report provides key details related to the Opioid-Induced Constipation industry like the product definition, cost, variety of applications, demand and supply statistics are covered in this research report.

Opioid-Induced Constipation Market report offers the following key points:

• Opioid-Induced Constipation Market share assessments for the regional and country level segments.

• Market share analysis of the top industry players.

• Strategic recommendations of Opioid-Induced Constipation market for the new entrants.

• Opioid-Induced Constipation Market forecasts for future years of all the mentioned segments, sub-segments and the regional markets.

• Opioid-Induced Constipation Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations).

• Competitive outlook is mapping the key common trends of Opioid-Induced Constipation industry.

• Company profiling with its detailed strategies, financials, and recent developments.

• The report provides supply chain trends mapping the latest technological advancements in Opioid-Induced Constipation industry.

• Strategic recommendations in key business segments supported the Opioid-Induced Constipation market estimations.

Browse contents of Global Opioid-Induced Constipation Market Research Report 2019

Contacts

Trusted Business Insights
Shelly Arnold
Blogger & Influencer Marketing Executive
US: +1 646 568 9797
UK: +44 330 808 0580

Tags: , , , , , , , , , , , , , , , , , ,